Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change	Volume
29/10/26	€0.4900	-5.41%	4,608
28/10/26	€0.5180	-4.07%	21,519
27/10/26	€0.5400	-8.16%	25,690
26/10/26	€0.5880	-2.00%	4,503
23/10/26	€0.6000	+9.09%	10,656

Real-time Euronext Paris

More quotes

Real-time Euronext Paris 14:05:27 29/10/2026 +04			5-day change	1st Jan Change
0.4900 ^EUR	-5.41%		-10.91%	-43.55%

10-22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	1.72M 1.91M 1.59M 1.44M 2.69M 182M 2.72M 18.97M 7.56M 95.34M 7.18M 7.03M 303M	P/E 2024	-86x	P/E 2025	-1.62x
Enterprise Value	1.77M 1.97M 1.64M 1.48M 2.77M 188M 2.81M 19.59M 7.8M 98.42M 7.41M 7.25M 312M	EV / Sales 2024	0.84x	EV / Sales 2025	0.47x
Free-Float	98.02%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALKLA	Real-time
Deutsche Boerse AG	4YA	Delayed
Börse Stuttgart	4YA	Delayed
Boerse Muenchen	4YA	Real-time

10-22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE

Klarsen Stock

Stocks

ALKLA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news: Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Price Extremes

Managers and Directors: Klarsen

Latest insider transactions

Other IT Services & Consulting

Financials

Company Profile

Quotes

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

10-23	Klarsen : Comptes semestriels 2026
10-22	Klarsen : ALKLA-KLARSEN Résultat 1er semestre 2026
10-22	KLARSEN : Résultats semestriels 2026
10-22	Klarsen : ALKLA – Résultats du premier semestre 2026 – 22 Octobre 2026
10-16	ALKLA – Assemblées générales 2026 : l’ensemble des résolutions adopté Klarsen ouvre une nouvelle séquence de développement – 16 Octobre 2026

1 day	-5.41%
1 week	-10.91%
Current month	-12.81%
1 month	-14.63%
3 months	-31.75%
6 months	+64.43%
Current year	-43.55%

1 week	0.48	0.64
1 month	0.48	0.68
Current year	0.22	1.68
1 year	0.22	1.68
3 years	0.22	3.48
5 years	0.22	4.03
10 years	0.11	5.4

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	23/03/2011

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/03/22	Parrou Julien	Buy		2,617	0.0790%
28/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,011	0.0909%
28/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,000	0.0905%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	-5.41%	-10.91%	-41.25%	-78.97%	1.91M
IBM	+1.19%	+0.70%	-18.99%	+77.67%	239B
SALESFORCE, INC.	+0.51%	+0.14%	-4.78%	+23.17%	199B
ACCENTURE PLC	+3.50%	+1.31%	-3.93%	-16.08%	144B
SNOWFLAKE INC.	+0.74%	+5.32%	+27.28%	+137.07%	120B
CLOUDFLARE, INC.	-2.77%	+3.74%	+42.29%	+475.83%	113B
TATA CONSULTANCY SERVICES LTD.	+0.73%	-1.15%	-18.96%	-26.65%	93.45B
RELX PLC	+0.35%	-4.05%	-14.45%	+1.72%	66.94B
INFOSYS LIMITED	+2.08%	-0.59%	-24.09%	-16.74%	47.77B
FUJITSU LIMITED	-2.88%	-5.49%	+12.58%	+127.12%	48.79B
Average	-2.06%	-0.53%	-4.43%	+70.41%	107.26B
Weighted average by Cap.	-2.36%	+0.78%	-1.18%	+87.96%

	2024	2025
Net sales	6.15M 6.85M 5.69M 5.15M 9.62M 653M 9.74M 67.98M 27.08M 342M 25.72M 25.18M 1.08B	6.2M 6.91M 5.73M 5.19M 9.7M 658M 9.82M 68.56M 27.31M 345M 25.94M 25.39M 1.09B
Net income	-47.76K -53.24K -44.16K -39.99K -74.72K -5.07M -75.62K -528K -210K -2.65M -200K -196K -8.42M	-1.95M -2.18M -1.8M -1.63M -3.05M -207M -3.09M -21.57M -8.59M -108M -8.16M -7.99M -344M
Net Debt	1.08M 1.2M 999K 905K 1.69M 115M 1.71M 11.95M 4.76M 60.03M 4.52M 4.42M 191M	55.36K 61.7K 51.18K 46.36K 86.6K 5.88M 87.65K 612K 244K 3.08M 232K 227K 9.76M